SEARCH

SEARCH BY CITATION

This index was compiled from the keywords

(P = Proceedings, S = Supplement)

Adverse drug reaction, 335

Adenosine, 562P

Angina pectoris, 553P

Antibiotics, 556P

Antidepressants, 561P

Apolipoprotein E-genotypes, 559P

Asthma, 679

Benzodiazepines, 556P

Biomarkers, 556P, 561P

Bosentan, 561P

Brain parenchyma, 548

Calcium channel blocker, 679

Cerebrospinal fluid, 560P

Cisapride, 680

Cisplatin, 554P

Coagulation, 563P

Cyclosporin, 334

CYP2C9, 183

CYP2C19, 553P

Desirudin, 563P

Dihydropyridine calcium channel blockers, 334

Diltiazem, 679

Dipyridamole, 562P

Drug leaflets, 678

Double injection technique, 333

Drug safety monitoring, 335

Ebastine, 682

Endothelin receptor antagonist, 561P

Endothelium, 558P

Fosfomycin, 548

Functional dyspepsia, 557P

Gastrointestinal motility, 557P

Gemcitabine, 554P

Hypoglycaemia, 550

Intravenous antibiotic therapy, 556P

In vivo pharmacology, 333

Isometric exercise, 562P

Lansoprazole, 553P

Losartan, 183

Midazolam, 560P

Motilin, 557P

Nasal drug delivery, 560P

Neonates, 555P

Nitrate therapy, 553P

Non-small cell lung cancer, 554P

Oedema, 334

Omeprazole, 553P

Oral antibiotic therapy, 556P

Pharmacokinetics, 553P, 555P

Pregnane X nuclear receptor, 561P

Pressor reflex, 562P

QT interval, 680, 681, 682

Quality of life, 553P

Recombinant hirudin, 563P

REM sleep, 561P

Safety instructions, 678

Serotonergic drugs, 680, 681

Skin microdialysis, 333

Statins, 559P

Sulphonylurea drugs, 550

Terfenadine, 682

Tissue plasminogen factor, 558P

Vancomycin, 555P